Jun 17, 2020
Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
Jun 03, 2020
Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress
May 26, 2020
Psychedelics Begin Gradual Climb to Medical Status
May 26, 2020
Emmes Announces its Contribution to NIH ACTT Clinical Trial for Remdesivir
May 25, 2020
/R E P E A T -- New Wave Holdings Sponsors Non-Profit Coalition, Therapsil, to Launch a Medical Psilocybin Access Project for Canadians in Palliative Care/
May 24, 2020
New Wave Holdings Sponsors Non-Profit Coalition, Therapsil, to Launch a Medical Psilocybin Access Project for Canadians in Palliative Care
May 18, 2020
Enzychem Lifesciences Appoints Duke Medical Coronavirus Task Force Expert Dr. Cameron Wolfe to Lead Development of EC-18 as a COVID-19 Therapeutic Drug
May 07, 2020
Magic Mushrooms Could Be the Next Investment Trend
May 05, 2020
Rigel Reports First Quarter 2020 Financial Results and Provides Business Update
Apr 27, 2020
COVID-19 Shutdown Forces Yes on IP 34, Oregon's Psilocybin Therapy Initiative, to Change Petition Strategy in Order to Collect Remaining 15,000 Signatures
Apr 27, 2020
Mental Health Care Company COMPASS Pathways Concludes Successful Series B Investment Round
Apr 27, 2020
Rigel Announces Conference Call and Webcast to Report First Quarter 2020 Financial Results and Business Update
Apr 23, 2020
Scientists Worldwide Feverishly Working to Develop New Drug and Vaccine Candidates for COVID-19 Crisis
Apr 08, 2020
Biotechs Fast Track Repurposing Existing Drugs for COVID-19 Treatments
Mar 20, 2020
University Hospitals among first in nation to test investigational antiviral drug against COVID-19
Feb 27, 2020
Rigel Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Feb 27, 2020
Segal Trials Screens its First Patient in a study of Psilocybin for Major Depressive Disorder
Feb 20, 2020
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results
Jan 13, 2020
Rigel Pharmaceuticals Provides Business Update
Jan 09, 2020
Rigel to Present at the 38th Annual J.P. Morgan Healthcare Conference